| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $14.2M | -22.8% |
| R&D Expense | $68.6M | -17.1% |
| SG&A Expense | $18.8M | +8.6% |
| Operating Income | -$73.2M | +10.4% |
| Interest Expense | $687K | -23.5% |
| Pre-tax Income | -$64.7M | +14.5% |
| Income Tax | $230K | — |
| Net Income | -$64.9M | +14.2% |
| EPS (Basic) | -$0.99 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $112.5M | +70.6% |
| Accounts Receivable | $6.5M | -5.3% |
| Current Assets | $147.2M | +44.1% |
| Total Assets | $170.5M | +35.2% |
| Current Liabilities | $35.6M | +28.8% |
| Long-term Debt | $2.9M | -53.0% |
| Total Liabilities | $67.9M | +86.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.0M | +69.7% |
| Capital Expenditures | $5.0M | -60.1% |
| Investing Cash Flow | -$5.0M | +60.1% |
| Financing Cash Flow | $72.3M | — |
| Free Cash Flow | -$25.0M | +68.2% |
| +57.0% |
| EPS (Diluted) | -$0.99 | +57.0% |
| Stockholders' Equity |
| $102.5M |
| +14.4% |